Aqsa Ullah

Aqsa Ullah practices at AdventHealth Orlando in Orlando, Florida, part of AdventHealth.

Aqsa Ullah's NPI, 1649710799, was assigned on March 7, 2017. Aqsa Ullah graduated from Dr. Kiran C. Patel College of Osteopathic Medicine in 2017. Aqsa Ullah holds Florida license UO5571.

Aqsa Ullah's primary practice is AdventHealth Orlando, at 601 E Rollins St, Orlando, FL 32803 in Orange County. The practice phone is (407) 303-1976.

Aqsa Ullah's primary practice is AdventHealth Orlando in Orlando, Florida, part of AdventHealth. Aqsa Ullah is also affiliated with AdventHealth Waterman. The medical group on file is AdventHealth Medical Group. Dmand AI also links Aqsa Ullah to 1 more hospital, 2 group practices and clinics, 2 medical groups and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Aqsa Ullah practices, 6 sites in all. Vendor and product names are available with a free account.

Neurology is Aqsa Ullah's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Aqsa Ullah is board certified in neurology by the American Board of Psychiatry and Neurology. Aqsa Ullah is licensed in Florida.

Dmand AI lists carpal tunnel syndrome, hereditary polyneuropathy, lower back pain, muscle weakness and neuropathy among the conditions Aqsa Ullah treats.

CMS data shows 274 Medicare services from Aqsa Ullah across 10 procedure codes in 2024, for 138 Medicare patients. Medicare paid $25,340 for them. Every service was in an office.

CMS counts 138 Medicare patients who saw Aqsa Ullah in 2024. The largest group is 65 to 74, with 61 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Aqsa Ullah's median patient age at 60, with 59% women.

In 2024, Aqsa Ullah wrote 470 Medicare Part D claims for 78 patients. 86% of them were for generic drugs. CMS names the drug for 386 of them, across 12 drugs with 11 or more claims each, at $431,488 in total drug cost. In 2023, CMS named 157 claims across 5 drugs.

Aqsa Ullah accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Aqsa Ullah as offering telehealth.

Dmand AI links 2 papers to Aqsa Ullah in 2019. 2019 was the busiest year, with 2. Aqsa Ullah has published most often in Cureus. Aqsa Ullah's most frequent co-authors are Yassar Chakfe, MD, Ankur Garg, MD and Joseph Michael Rios, MD.

CMS Open Payments shows 29 general payments to Aqsa Ullah from 8 drug and device companies from 2020 to 2025. Travel and lodging make up the largest share, 70% of the total. Novartis Pharmaceuticals Corporation paid the most, $2,641.

Aqsa Ullah graduated from Dr. Kiran C. Patel College of Osteopathic Medicine in 2017.

Aqsa Ullah is in network with 19 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.